Application no. and date | 17797564.6 (espacenet) (Federated) (European Patent Register), 20171027 | Patent/reg. no. and date | DK/EP 3532098, 20210407 | Publication date | 20190904 | Priority no. and date | EP 16196184, 20161028 | EP pub. no. and date |
EP 3532098 20190904 | Effective date | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington
Delaware 19803
, US | Applicant ref. no. | P76158DK01 | Inventor | ENDELL, Jan, Barer Str. 36
80333 Munich, DE, PETROPOULOS, Konstantin, Goegglstrasse 39a
80997 Munich, DE, RÜCKERT, Markus, Johannishöhe 60
82288 Kottgeisering, DE, BOXHAMMER, Rainer, Birkenstraße 4a
83059 Kolbermoor, DE, KELEMEN, Peter, Packenreiterstr. 3
81247 Munich, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | KOMBINATION AF ANTI-CD19-ANTISTOF MED EN BCL-2-INHIBITOR OG ANVENDELSER DERAF | Int. application no. | EP2017077654 | Int. publication no. | WO2018078123 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|